Go Pro
NYSE:AMWL

American Well Q2 2026 Earnings Report

American Well logo
$10.77 -0.07 (-0.67%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$10.77 +0.00 (+0.03%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

American Well EPS Results

Actual EPS
N/A
Consensus EPS
-$0.60
Beat/Miss
N/A
One Year Ago EPS
N/A

American Well Revenue Results

Actual Revenue
N/A
Expected Revenue
$49.88 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

American Well Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Tuesday, August 4, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

American Well Earnings Headlines

1 Stock to Own by July 31st
A scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-known name may be positioned to benefit while the Magnificent 7 stumbles. Smaller, overlooked stocks are showing growing potential to challenge AI's biggest players. One specific ticker stands out heading into that date.tc pixel
Wells Fargo Remains a Buy on American Well (AMWL)
See More American Well Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like American Well? Sign up for Earnings360's daily newsletter to receive timely earnings updates on American Well and other key companies, straight to your email.

About American Well

American Well (NYSE:AMWL), operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration. In addition, American Well provides white-label solutions that allow hospitals, health systems and health plans to brand and manage their own telehealth services. Its suite of services also extends to medical device integration for real-time monitoring, population health analytics and specialized telepsychiatry, enabling partners to deliver comprehensive care remotely.

Founded in 2006 by Dr. Ido Schoenberg and brothers Roni and Roy Schoenberg, American Well pioneered the digital health sector by forging early partnerships with leading health systems and insurers in the United States. Over time, the company has expanded its footprint beyond North America, collaborating with healthcare organizations and technology partners in Europe, Asia and Latin America. Its platform is designed to comply with regional privacy and data security regulations, including HIPAA in the U.S. and GDPR in Europe.

Under the leadership of CEO Ido Schoenberg, American Well has focused on advancing telehealth interoperability, user experience and clinical quality. The executive team includes seasoned professionals from healthcare, technology and regulatory backgrounds, supporting a mission to make telemedicine an integral part of mainstream care delivery. As telehealth adoption grows globally, American Well continues to invest in platform enhancements, strategic partnerships and new care modalities to meet evolving provider and patient needs.

View American Well Profile